...
首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >Design, synthesis and biological evaluation of 6-substituted aminocarbonyl benzimidazole derivatives as nonpeptidic angiotensin II AT1 receptor antagonists.
【24h】

Design, synthesis and biological evaluation of 6-substituted aminocarbonyl benzimidazole derivatives as nonpeptidic angiotensin II AT1 receptor antagonists.

机译:设计,合成和生物评估的6-取代的氨基羰基苯并咪唑衍生物作为非肽血管紧张素II AT1受体拮抗剂。

获取原文
获取原文并翻译 | 示例

摘要

A series of 6-substituted aminocarbonyl benzimidazole derivatives were designed and synthesized as nonpeptidic angiotensin II AT(1) receptor antagonists. The preliminary pharmacological evaluation revealed nanomolar AT(1) receptor binding affinity and good AT(1) receptor selectivity over AT(2) receptor for all compounds of the series, a potent antagonistic activity in isolated rabbit aortic strip functional assay for compounds 6b, 6d and 6i was also demonstrated. Furthermore, evaluation in spontaneous hypertensive rats and a preliminary toxicity evaluation showed that compound 6i is an orally active AT(1) receptor antagonist with low toxicity.
机译:设计并合成了一系列6-取代的氨基羰基苯并咪唑衍生物作为非肽血管紧张素II AT(1)受体拮抗剂。初步药理评估显示,该系列所有化合物均具有纳摩尔AT(1)受体结合亲和力和优于AT(2)受体的良好AT(1)选择性,在分离的兔主动脉带功能性化合物6b,6d中具有强大的拮抗活性并且还演示了6i。此外,在自发性高血压大鼠中的评估和初步毒性评估表明,化合物6i是一种口服活性AT(1)受体拮抗剂,具有低毒性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号